- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
CACNA1D Antibody / CaV1.3 Polyclonal Antibody targets the alpha-1D subunit of voltage-dependent L-type calcium channels, encoded by the CACNA1D gene. Also known as CaV1.3, this protein forms the ion-conducting pore of a calcium channel complex that regulates calcium entry in response to changes in membrane potential. Calcium influx through CaV1.3 channels contributes to electrical excitability, neurotransmitter release, hormone secretion, and calcium-dependent gene regulation. The protein belongs to the CaV1 family of voltage-gated calcium channels, whose members share a conserved architecture but differ in their electrophysiological properties, tissue distribution, and physiological functions.
CaV1.3 channels activate at relatively negative membrane potentials, allowing them to participate in calcium signaling during modest membrane depolarization. This characteristic distinguishes CaV1.3 from CaV1.2 and contributes to its specialized roles in electrically active cells. In cochlear inner hair cells, CaV1.3-mediated calcium entry triggers synaptic vesicle fusion and neurotransmitter release, enabling auditory signal transmission. The channel also contributes to pacemaker activity in the sinoatrial node and selected neuronal populations, where sustained calcium entry influences rhythmic firing and cellular signaling.
The alpha-1D subunit contains four homologous domains, each comprising six transmembrane segments. These domains form the voltage-sensing and calcium-conducting regions of the channel. Auxiliary beta and alpha-2/delta subunits regulate channel trafficking, membrane localization, and functional properties. CaV1.3 activity is further controlled by calcium-dependent inactivation, interactions with regulatory proteins, and alternative splicing of CACNA1D transcripts. Splice variants can exhibit different activation thresholds and inactivation kinetics, providing mechanisms for adjusting calcium signaling to the requirements of individual cell types.
Genetic alterations affecting CACNA1D have been associated with auditory dysfunction, endocrine abnormalities, and neurological disorders. Certain gain-of-function variants increase calcium channel activity and have been identified in aldosterone-producing adrenal lesions, where excessive calcium signaling promotes aldosterone synthesis. Other variants influence neuronal excitability and developmental signaling. These findings have established CaV1.3 as an important subject in studies of channel regulation, calcium-dependent secretion, and electrical activity. Research using a CACNA1D Antibody can contribute to understanding the expression and molecular regulation of this channel and its involvement in physiological and pathological calcium signaling.
For an alternative antibody targeting this voltage-gated calcium channel, see our CaV1.3 Antibody (R31742), which has additional validation data for flow cytometry.
The stated application concentrations are suggested starting amounts. Titration of the CACNA1D Antibody / CaV1.3 Polyclonal Antibody may be required due to differences in protocols and secondary/substrate sensitivity.
An amino acid sequence from the C-terminus of human CaV1.3/CACNA1D (RDEEDLADEMICITTL) was used as the immunogen for this CACNA1D antibody.
After reconstitution, the CACNA1D antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
CaV1.3 antibody, Calcium channel alpha-1D subunit antibody, Voltage-dependent L-type calcium channel subunit alpha-1D antibody, L-type calcium channel alpha-1D antibody, Voltage-gated calcium channel alpha-1D antibody, Calcium channel voltage-dependent L type alpha 1D subunit antibody, Alpha-1D calcium channel antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.